SCRS Sites Directory

Search SCRS member sites. Discover current trials.

Integrative Clinical Trials (ICT) is a multi-specialty dedicated research facility located in the heart of South Brooklyn, New York. We specialize in conducting clinical research studies on a wide spectrum of Central Nervous System disorders as well as Medical indications such as Alzheimers Disease / Mild Cognitive Impairment, Schizophrenia, Depression, Bipolar Disorder, Diabetes, Hypertension, Post-Herpetic Neuralgia, Smoking Cessation, Headache disorders and much more.

Our team includes Inna Yuryev-Golger, MD, one of our Principal Investigators who has been serving the community with quality, compassionate care for over 15 years and has over 10 years of clinical research trial experience. Dr. Golger has conducted over 60+ clinical research trials throughout her career. Dr. Golger founded ICT in 2012 in collaboration with Dr. Yuryev with a common vision to discover new and effective treatments for the very challenging disorder and conditions they have encountered in their daily practices. Our team of highly experienced professionals and clinical research coordinators is dedicated in bringing promising treatments to the patients who rely on them. The ICT team is highly capable of providing on-time, on schedule, quality, accurate and reproducible data to our clinical trial and pharmaceutical sponsors.

Our prime central location allows us to serve a diverse population of patients both treatment naïve and not naïve. Some study participants are recruited from our extensive private practice database to offer novel treatment options when traditional therapies are inadequate as well as providing treatment options to underserved populations who otherwise would have difficulty obtaining medical care for their conditions.

Our facility is easily accessible via mass transit to serve our patients and is fully ADA Compliant to aid those patients with disabilities.


Demographic Data

  • Start year clinical research2012
  • Phases of clinical studiesPhase I, Phase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals
  • PopulationsAdult 18-64 yrs, Senior 65 yrs and over
  • Type of siteFreestanding
  • # of employees involved in research7
  • # of investigators2
  • Number of studies last year10
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday
  • Extended office hoursYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL
  • Contact for regulatory documentsLyudmila Grishina
  • Regulatory phone number718-444-7774
  • # of days to turn around regulatory documents10 business days
  • Type of IRB used by this siteCentral
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • # days to turn around budget and contract10 business days